Herbalife Ltd. (NYSE:HLF) Director Purchases $21,225.00 in Stock

Herbalife Ltd. (NYSE:HLF) Director Juan Miguel Mendoza acquired 2,500 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $8.49 per share, with a total value of $21,225.00. Following the purchase, the director now owns 127,500 shares of the company’s stock, valued at approximately $1,082,475. This trade represents a 2.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.

Juan Miguel Mendoza also recently made the following trade(s):

• On Monday, November 4th, Juan Miguel Mendoza acquired 2,500 shares of Herbalife stock. The shares were bought at an average cost of $7.98 per share, with a total value of $19,950.00.
• On Monday, September 9th, Juan Miguel Mendoza purchased 10,000 shares of Herbalife stock. The shares were purchased at an average cost of $7.11 per share, with a total value of $71,100.00.
• On Monday, August 26th, Juan Miguel Mendoza bought 10,000 shares of Herbalife stock. The stock was acquired at an average cost of $8.72 per share, with a total value of $87,200.00.

Herbalife Price Performance

NYSE HLF opened at $7.92 on Friday. Herbalife Ltd. has a 1 year low of $6.59 and a 1 year high of $15.66. The company has a market capitalization of $798.27 million, a PE ratio of 9.32, a P/E/G ratio of 0.29 and a beta of 1.17. The company has a fifty day moving average of $7.32 and a 200 day moving average of $9.25.

Herbalife (NYSE:HLF) last posted its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.38. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%. The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.23 billion. Research analysts expect that Herbalife Ltd. will post 1.51 earnings per share for the current year.

Institutional Trading of Herbalife

A number of hedge funds have recently bought and sold shares of HLF. Geode Capital Management LLC raised its holdings in shares of Herbalife by 4.2% in the 3rd quarter. Geode Capital Management LLC now owns 2,615,514 shares of the company’s stock valued at $18,809,000 after buying an additional 105,431 shares during the period. Barclays PLC lifted its position in shares of Herbalife by 347.0% during the third quarter. Barclays PLC now owns 161,426 shares of the company’s stock worth $1,160,000 after purchasing an additional 125,311 shares in the last quarter. Prentice Capital Management LP lifted its position in shares of Herbalife by 27.0% during the third quarter. Prentice Capital Management LP now owns 233,851 shares of the company’s stock worth $1,681,000 after purchasing an additional 49,747 shares in the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in shares of Herbalife by 15.5% in the third quarter. Jacobs Levy Equity Management Inc. now owns 1,539,148 shares of the company’s stock valued at $11,066,000 after purchasing an additional 206,530 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC grew its holdings in shares of Herbalife by 20.2% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 2,287,600 shares of the company’s stock valued at $16,448,000 after purchasing an additional 384,100 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HLF. Citigroup decreased their price objective on Herbalife from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. StockNews.com upgraded Herbalife from a “hold” rating to a “buy” rating in a research report on Monday, November 4th. B. Riley cut their price objective on shares of Herbalife from $17.00 to $12.00 and set a “buy” rating on the stock in a research report on Thursday, October 31st. DA Davidson lowered their target price on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating for the company in a report on Thursday, October 31st. Finally, Mizuho upped their price target on shares of Herbalife from $8.00 to $9.00 and gave the company a “neutral” rating in a report on Friday, November 1st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $9.90.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.